PMID- 32555351 OWN - NLM STAT- MEDLINE DCOM- 20201210 LR - 20240426 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 10 IP - 1 DP - 2020 Jun 17 TI - Fibronectin extra domain A (FN-EDA) elevates intraocular pressure through Toll-like receptor 4 signaling. PG - 9815 LID - 10.1038/s41598-020-66756-6 [doi] LID - 9815 AB - Elevated intraocular pressure (IOP) is a major risk factor for the development and progression of primary open angle glaucoma and is due to trabecular meshwork (TM) damage, which leads to impaired aqueous humor outflow. Here, we explore a novel molecular mechanism involved in glaucomatous TM damage. We investigated the role of an endogenous Toll-like receptor 4 (TLR4) ligand, fibronectin-EDA (FN-EDA), in TGFbeta2-induced ocular hypertension in mice. We utilized transgenic mouse strains that either constitutively express only FN containing the EDA isoform or contain an EDA-null allele and express only FN lacking EDA, with or without a mutation in Tlr4, in our inducible mouse model of ocular hypertension by injection of Ad5.TGFbeta2. IOP was measured over time and eyes accessed by immunohistochemistry for total FN and FN-EDA expression. Constitutively active EDA caused elevated IOP starting at 14 weeks of age. Ad5.TGFbeta2 induced ocular hypertension in wildtype C57BL/6J mice and further amplified the IOP in constitutively active EDA mice. TLR4 null and EDA null mice blocked Ad5.TGFbeta-induced ocular hypertension. Total FN and FN-EDA isoform expression increased in response to Ad5.TGFbeta2. These data suggest that both TLR4 and FN-EDA contribute to TGFbeta2 induced ocular hypertension. FAU - Roberts, Amanda L AU - Roberts AL AD - North Texas Eye Research Institute, Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas, United States. FAU - Mavlyutov, Timur A AU - Mavlyutov TA AD - Department of Ophthalmology and Visual Sciences, McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, United States. FAU - Perlmutter, Tanisha E AU - Perlmutter TE AD - Department of Ophthalmology and Visual Sciences, McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, United States. FAU - Curry, Stacy M AU - Curry SM AD - North Texas Eye Research Institute, Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas, United States. FAU - Harris, Sherri L AU - Harris SL AD - North Texas Eye Research Institute, Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas, United States. FAU - Chauhan, Anil K AU - Chauhan AK AD - Department of Internal Medicine, University of Iowa, Iowa City, IA, United States. FAU - McDowell, Colleen M AU - McDowell CM AD - Department of Ophthalmology and Visual Sciences, McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, United States. cmmcdowell@wisc.edu. LA - eng GR - P30 EY016665/EY/NEI NIH HHS/United States GR - R35 HL139926/HL/NHLBI NIH HHS/United States GR - U01 NS113388/NS/NINDS NIH HHS/United States GR - R01 HL118246/HL/NHLBI NIH HHS/United States GR - R01 HL118742/HL/NHLBI NIH HHS/United States GR - R25 GM125587/GM/NIGMS NIH HHS/United States GR - R01 EY026529/EY/NEI NIH HHS/United States GR - R01 NS109910/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20200617 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Fibronectins) RN - 0 (Toll-Like Receptor 4) RN - 0 (Transforming Growth Factor beta2) SB - IM MH - Animals MH - Fibronectins/*chemistry/*metabolism MH - Gene Expression Regulation MH - *Intraocular Pressure MH - Mice MH - Mice, Inbred C57BL MH - *Signal Transduction MH - Toll-Like Receptor 4/*metabolism MH - Trabecular Meshwork/cytology/metabolism MH - Transforming Growth Factor beta2/metabolism PMC - PMC7299944 COIS- The authors declare no competing interests. EDAT- 2020/06/20 06:00 MHDA- 2020/12/15 06:00 PMCR- 2020/06/17 CRDT- 2020/06/20 06:00 PHST- 2019/10/29 00:00 [received] PHST- 2020/05/27 00:00 [accepted] PHST- 2020/06/20 06:00 [entrez] PHST- 2020/06/20 06:00 [pubmed] PHST- 2020/12/15 06:00 [medline] PHST- 2020/06/17 00:00 [pmc-release] AID - 10.1038/s41598-020-66756-6 [pii] AID - 66756 [pii] AID - 10.1038/s41598-020-66756-6 [doi] PST - epublish SO - Sci Rep. 2020 Jun 17;10(1):9815. doi: 10.1038/s41598-020-66756-6.